+44 (0) 207 117 6375
MEET TUSCAN PHARMA
Our vision; to be global specialist, and partners, providing treatment solutions across several areas of focus, including: Cardiology, Endocrinology, Urology & General Practice. Delivering ongoing treatment solutions for physicians and patients, where other Pharma companies no longer support.
ABOUT TUSCAN PHARMA
Tuscan Pharma’s mission is to establish itself at the forefront of healthcare needs, providing specialised solutions in the UK and beyond. We strive to create long lasting partnerships with our customers and business associates based on trust, innovation, results and quality excellence.
​
We are dedicated to ensuring that we lead the healthcare industry in a variety of specialised products and areas of expertise. We are committed to improving health through continued production, and delivery of, important treatments that patients are established on, that other organisations no longer support.
OUR STRATEGY
We have a proven strategy of delivering organic growth through selective development and promotion of our brands, enhancing this growth through carefully targeted acquisitions.
Enhancing our growth through acquisitions
We take a selective approach to acquisitions, using them to increase the scale or geographic reach of our business, to bolster our presence in specific therapy areas or to deliver operational leverage.
We see exciting opportunities for brands to achieve more. Our alliances allow us to unlock potential and maximise the performance of every business and every brand. Our focus is on ensuring this potential is realised in the most effective way.
We look at potential differently, which means that we think and act creatively about our business. We are agile, scalable and adaptable, unconstrained by convention.
As an organisation we are constantly refining our skill set, knowledge and our entrepreneurial spirit and we surround ourselves with like-minded colleagues. Our purpose is to achieve more, knowing that working together brings a better outcome. We grow together as people and that, in turn, powers the growth of our business. We have identified a number of factors which are critical to the effective implementation of our strategy, and our focus will be on taking the actions necessary to ensure these are progressed.
OUR BUSINESS MODEL
Tuscan Pharma, headquartered in United Kingdom, is a rapidly growing pharmaceutical company engaged in the manufacture, acquisition, licensing, development, marketing, sale and distribution of pharmaceutical products for the UK and EU prescription drug market. Tuscan Pharma markets a variety of products to wholesalers, distributors and hospital providers. We operate a virtually integrated global supply network that leverages strategic outsourcing to the UK-MHRA, EU-EMA US-FDA approved manufacturing and development organisations across UK, EU, India and Far East.
Tuscan Pharma, products cover a number of therapeutic categories, including but not limited to: Cardiology, Endocrinology, Urology & General Practice.
The company owns a robust pipeline of multisource and high barrier products and will continue to introduce products during the coming years as its pipeline and partnerships matures. The foundation and advantage of our business model is the integration of a professionally qualified technical team, latest state of the art manufacturing facilities, strong commercial operations and sales team with a global supply chain network that provides access to low-cost development, materials and manufacturing capacity.
We remain pro-active in regards to growing our business appropriately to fit the current competitive environment, while maintaining a focus on creating value with quality pharmaceuticals with strategic focus on the needs of UK and EU market.
OUR PRIORITIES
Tuscan Pharma’s mission is to improve the quality of human life by enabling people to do more, feel better, live longer.
​
To achieve this mission we have a single minded focus on the core business strategy that delivers sustainable performance through innovation and expanding access, driven by our values across all business practices:
​
(i) Commitments
For Tuscan, how we deliver success is just as important as what we achieve. Ensuring our values are embedded in our business is a priority.
(ii) Oversight
We have a robust structure in place to ensure the approach we take on corporate responsibility is appropriate. Our board-level Corporate Responsibility Committee (CRC) has overall oversight and sits within a clear organisational structure that ensures accountability.
(iii) Stakeholder dialogue
We engage with a wide range of stakeholders through: day-to-day interactions with customers; engagement with governments and patient advocacy groups; regular dialogue with employees; suppliers, partners and investors.
Dialogue with these stakeholders enables us to understand how our business may affect – or be affected – by them. Their feedback helps us to identify and prioritise important issues and develop responses that are in the best interests of society, as well as our shareholders.
TUSCAN VALUES
Courage.
Breakthroughs start by challenging convention. This happens when we think big, speak up and are decisive.
Excellence.
We can only change patients’ lives when we perform at our best together. This happens when we focus on what matters, agree who does what and measure our outcomes.
Equity.
We believe that every person deserves to be seen, heard and cared for. This happens when we are inclusive, act with integrity and reduce health care disparities.
MEET THE TEAM
Keith Williams
Keith Williams stands with over two decades of experience shaping the landscape of this intricate and often overlooked domain. His expertise in operational excellence and strategic approaches has been meticulously honed through an extraordinary career that encompasses running his own companies, holding senior positions in esteemed pharmaceutical firms, and providing expert guidance to clients across the globe.
Keith’s profound understanding of rare diseases is rooted in his first hand experience managing and commercializing rare disease products and unlicensed medicines across the UK, Ireland, Nordics, and the EU. His ability to identify and implement unconventional and innovative approaches to market entry and launch has cemented his reputation as a trusted advisor to organizations striving to bring life-altering therapies to patients battling rare disorders.
​
His extensive experience in general management, commercial, and sales & marketing roles with leading companies like GSK, MSD, LEO, and Lediant Biosciences has further enriched his expertise. This multifaceted experience has equipped him with a comprehensive perspective on the entire drug development and commercialization process, enabling him to provide unparalleled guidance to clients from inception to market triumph.
​
Keith’s leadership and strategic acumen are instrumental in steering clients towards success, empowering them to overcome obstacles and achieve their commercial objectives. His solutions-oriented approach and unwavering dedication to patient well-being render him an invaluable asset to any organization seeking to make a transformative impact on the lives of those affected by rare diseases.
​
With his unwavering commitment to excellence and his passion for improving the lives of patients, Keith Williams continues to stand as a beacon of hope in the fight against rare diseases. His legacy is one of innovation, collaboration, and a deep-seated belief in the power of science to transform the lives of those touched by these challenging conditions.
​